PPA
HOOK

Parametric Portfolio Associates’s HOOKIPA Pharma HOOK Stock Holding History

Parametric Portfolio Associates’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$144K Buy
6,314
+4,428
+235% +$79.4K ﹤0.01% 3504
2021
Q4 		$44K Buy
+1,886
New +$75.8K ﹤0.01% 3604

Other funds holding HOOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Parametric Portfolio Associates's HOOK Position: Q1 2022 in Review

Parametric Portfolio Associates increased its HOOKIPA Pharma (HOOK) stake by 235% in Q1 2022, buying an estimated $79.4K and bringing the position to 6,314 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #3504.

Parametric Portfolio Associates first reported a position in HOOK in Q4 2021 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold HOOK as of Q1 2022.

  • Parametric Portfolio Associates held 6,314 shares of HOOKIPA Pharma worth $144K as of Q1 2022.
  • Parametric Portfolio Associates bought 4,428 HOOKIPA Pharma shares in Q1 2022, an estimated $79.4K.
  • HOOKIPA Pharma made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3504 holding.
  • Parametric Portfolio Associates first reported a position in HOOKIPA Pharma in Q4 2021 and has held it in 2 quarters since.
  • 74 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.